The role of complement in tumor immune tolerance and drug resistance: a double-edged sword
The domain of cancer treatment has persistently been confronted with significant challenges, including those associated with recurrence and drug resistance. The complement system, which serves as the foundation of the innate immune system, exhibits intricate and nuanced dual characteristics in the e...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1529184/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832576348983394304 |
---|---|
author | Ronghui Yang Di Fu Di Fu Aijun Liao |
author_facet | Ronghui Yang Di Fu Di Fu Aijun Liao |
author_sort | Ronghui Yang |
collection | DOAJ |
description | The domain of cancer treatment has persistently been confronted with significant challenges, including those associated with recurrence and drug resistance. The complement system, which serves as the foundation of the innate immune system, exhibits intricate and nuanced dual characteristics in the evolution of tumors. On the one hand, the complement system has the capacity to directly inhibit cancer cell proliferation via specific pathways, thereby exerting a beneficial anti-tumor effect. Conversely, the complement system can also facilitate the establishment of an immune escape barrier for cancer cells through non-complement-mediated mechanisms, thereby protecting them from eradication. Concurrently, the complement system can also be implicated in the emergence of drug resistance through a multitude of complex mechanisms, directly or indirectly reducing the efficacy of therapeutic interventions and facilitating the progression of cancer. This paper analyses the role of the complement system in tumors and reviews recent research advances in the mechanisms of tumor immune tolerance and drug resistance. |
format | Article |
id | doaj-art-852999b2927046bdbc68ba8b01d3f6cc |
institution | Kabale University |
issn | 1664-3224 |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj-art-852999b2927046bdbc68ba8b01d3f6cc2025-01-31T06:39:54ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011610.3389/fimmu.2025.15291841529184The role of complement in tumor immune tolerance and drug resistance: a double-edged swordRonghui Yang0Di Fu1Di Fu2Aijun Liao3Department of Blood Transfusion, The First Hospital of China Medical University, Shenyang, Liaoning, ChinaDepartment of Hematology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, ChinaDepartment of General Practice, Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning, ChinaDepartment of Hematology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, ChinaThe domain of cancer treatment has persistently been confronted with significant challenges, including those associated with recurrence and drug resistance. The complement system, which serves as the foundation of the innate immune system, exhibits intricate and nuanced dual characteristics in the evolution of tumors. On the one hand, the complement system has the capacity to directly inhibit cancer cell proliferation via specific pathways, thereby exerting a beneficial anti-tumor effect. Conversely, the complement system can also facilitate the establishment of an immune escape barrier for cancer cells through non-complement-mediated mechanisms, thereby protecting them from eradication. Concurrently, the complement system can also be implicated in the emergence of drug resistance through a multitude of complex mechanisms, directly or indirectly reducing the efficacy of therapeutic interventions and facilitating the progression of cancer. This paper analyses the role of the complement system in tumors and reviews recent research advances in the mechanisms of tumor immune tolerance and drug resistance.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1529184/fullcomplement systemtumoranti-tumorimmune tolerancedrug resistance |
spellingShingle | Ronghui Yang Di Fu Di Fu Aijun Liao The role of complement in tumor immune tolerance and drug resistance: a double-edged sword Frontiers in Immunology complement system tumor anti-tumor immune tolerance drug resistance |
title | The role of complement in tumor immune tolerance and drug resistance: a double-edged sword |
title_full | The role of complement in tumor immune tolerance and drug resistance: a double-edged sword |
title_fullStr | The role of complement in tumor immune tolerance and drug resistance: a double-edged sword |
title_full_unstemmed | The role of complement in tumor immune tolerance and drug resistance: a double-edged sword |
title_short | The role of complement in tumor immune tolerance and drug resistance: a double-edged sword |
title_sort | role of complement in tumor immune tolerance and drug resistance a double edged sword |
topic | complement system tumor anti-tumor immune tolerance drug resistance |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1529184/full |
work_keys_str_mv | AT ronghuiyang theroleofcomplementintumorimmunetoleranceanddrugresistanceadoubleedgedsword AT difu theroleofcomplementintumorimmunetoleranceanddrugresistanceadoubleedgedsword AT difu theroleofcomplementintumorimmunetoleranceanddrugresistanceadoubleedgedsword AT aijunliao theroleofcomplementintumorimmunetoleranceanddrugresistanceadoubleedgedsword AT ronghuiyang roleofcomplementintumorimmunetoleranceanddrugresistanceadoubleedgedsword AT difu roleofcomplementintumorimmunetoleranceanddrugresistanceadoubleedgedsword AT difu roleofcomplementintumorimmunetoleranceanddrugresistanceadoubleedgedsword AT aijunliao roleofcomplementintumorimmunetoleranceanddrugresistanceadoubleedgedsword |